Where does Vaxxas Pty Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vaxxas Pty Limited ranks #19,319 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vaxxas Pty Limited hold?

Vaxxas Pty Limited holds 15 US utility patents granted between 2018 and 2024, spanning 13 technology areas.

What is Vaxxas Pty Limited's Innovation Score?

Vaxxas Pty Limited has an Innovation Score of 38.9 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Vaxxas Pty Limited's patent grant rate increasing or decreasing?

Vaxxas Pty Limited's recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Vaxxas Pty Limited's patents?

Vaxxas Pty Limited's patents average 16.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vaxxas Pty Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Vaxxas Pty Limited

Q: What technology areas does Vaxxas Pty Limited focus on?

Vaxxas Pty Limited's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 13 patents, ranking #542 of 3,490 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 15 granted patents across 13 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vaxxas ranks #19,319 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 13 technology areas.

#19,319
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.9/100): 16.5
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19319 · Foreign Corporation #19,319 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #19,319/49,997
PHOTO-FINISH Valo Early Discovery
CPC-FOCUS A61M · 13 areas
INNOV-THIN 38.9/100
CLAIMS-RICH 16.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Valo Early Discovery, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vaxxas’s 38.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (25%) Velocity 6.7 pts (17%) Breadth 12.7 pts (33%) Claim depth 9.9 pts (25%)

Qualcomm Incorporated · highest

85
Vaxxas Pty · this assignee

39
3D Lighting… · lowest

7

What this shows Vaxxas's Innovation Score is 38.9/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vaxxas?

Each dot is one of Vaxxas’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vaxxas’s own 16.5 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vaxxas vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vaxxas's grants concentrate

Vaxxas Pty Limited is a focused PatentsView assignee: 13 CPC subclasses with 86.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2020. By volume, Vaxxas sits between VT Idirect, Inc. and Verona Pharma PLC.

Vaxxas's three-year grant acceleration

Vaxxas Pty Limited shows 6 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

VT Idirect

15
Valo Early Discov…

15
Valve Medical

15
Vascular Imaging

15
Vedanta Bioscienc…

15
Venturemed Group

15
Veritone Alpha

15
Verona Pharma

15
Vaxxas Pty ◀

15

What this shows Vaxxas holds 15 patents at rank #19,321, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vaxxas

By rank, the assignees closest to #19,321 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Vaxxas's primary technology class.

Vaxxas's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Vaxxas Pty Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	20.0%
2020	1	6.7%
2021	5	33.3%
2022	2	13.3%
2023	2	13.3%
2024	2	13.3%

Which technologies does Vaxxas Pty Limited patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 13

A61B - DIAGNOSIS; SURGERY; Identification 8

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 2

H10N - Electric Solid-state Devices NOT Otherwise Provided FOR 2

B41J - TYPEWRITERS; Selective Printing Mechanisms, i.e. Mechanisms Printing Otherwise Than From A FORME; Correction OF Typographical Errors 2

B05C - Apparatus FOR Applying Fluent Materials TO Surfaces, IN General 2

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61D - Veterinary Instruments, Implements, Tools, OR Methods 1

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vaxxas Pty Limited's patent record in context - here's where to go next.

Vaxxas Pty Limited's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 86.7% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #19,319 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vaxxas Pty Limited against VT Idirect, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.